Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches by Thai-Son Tran, Minh-Tri Le, Thanh-Dao Tran, The-Huan Tran, Khac-Minh Thai

Subjects: Get full text

Acute exercise and brain BACE1 protein content: a time course study by Alex J. Yang, Grant C. Hayward, Rebecca E. K. MacPherson

Subjects: Get full text

Examination of BDNF Treatment on BACE1 Activity and Acute Exercise on Brain BDNF Signaling by Bradley J. Baranowski, Grant C. Hayward, Daniel M. Marko, Rebecca E. K. MacPherson, Rebecca E. K. MacPherson

Subjects: Get full text

Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer’s Disease by Martha Cecilia Rosales Hernández, Marycruz Olvera-Valdez, Jazziel Velazquez Toledano, Jessica Elena Mendieta Wejebe, Leticia Guadalupe Fragoso Morales, Alejandro Cruz

Subjects: Get full text

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology by Gerald Koelsch

Subjects: Get full text

Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines by Alessio Colombo, Huanhuan Wang, Peer-Hendrik Kuhn, Richard Page, Elisabeth Kremmer, Peter J. Dempsey, Howard C. Crawford, Stefan F. Lichtenthaler

Subjects: Get full text

Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties by De-Yang Sun, Chen Cheng, Katrin Moschke, Jian Huang, Wei-Shuo Fang

Subjects: “…beta-secretase…”
Get full text

Implications of Microorganisms in Alzheimer’s Disease by Pardeep Yadav, Yeon-Hee Lee, Hrithika Panday, Shubham Kant, Neha Bajwa, Ritika Parashar, Saurabh Kumar Jha, Niraj Kumar Jha, Parma Nand, Sang-Soo Lee, Abhimanyu Kumar Jha

Subjects: Get full text

Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition by Suwanttananuruk Piyapan, Jiaranaikulwanitch Jutamas, Waiwut Pornthip, Vajragupta Opa

Subjects: Get full text

Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission by Tugce Munise Satir, Lotta Agholme, Anna Karlsson, Mattias Karlsson, Paul Karila, Sebastian Illes, Petra Bergström, Henrik Zetterberg

Subjects: Get full text

Identification of Potential Multitarget Compounds against Alzheimer’s Disease through Pharmacophore-Based Virtual Screening by Géssica Oliveira Mendes, Moysés Fagundes de Araújo Neto, Deyse Brito Barbosa, Mayra Ramos do Bomfim, Lorena Silva Matos Andrade, Paulo Batista de Carvalho, Tiago Alves de Oliveira, Daniel Luciano Falkoski, Eduardo Habib Bechelane Maia, Marcelo Siqueira Valle, Laila Cristina Moreira Damázio, Alisson Marques da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite

Subjects: Get full text

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease by Tosin A. Olasehinde, Ademola O. Olaniran, Anthony I. Okoh

Subjects: Get full text

Evaluation of Selected Plant Phenolics via Beta-Secretase-1 Inhibition, Molecular Docking, and Gene Expression Related to Alzheimer’s Disease by Tugba Uçar Akyürek, Ilkay Erdogan Orhan, F. Sezer Şenol Deniz, Gokcen Eren, Busra Acar, Alaattin Sen

Subjects: Get full text

Can Neurostimulation Prevent the Risk of Alzheimer’s Disease in Elderly Individuals with Schizophrenia? by Adonis eSfera, Adonis eSfera

Subjects: Get full text

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients by Martina Zimmermann, Barbara Borroni, Flaminio Cattabeni, Alessandro Padovani, Monica Di Luca

Subjects: Get full text

Voluntary wheel running alters markers of amyloid-beta precursor protein processing in an ovarian hormone depleted model by Ahmad Mohammad, Michael S. Finch, Jacob Sweezey-Munroe, Rebecca E. K. MacPherson, Rebecca E. K. MacPherson

Subjects: Get full text

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease by Madhurima Chatterjee, Marta Del Campo, Tjado H. J. Morrema, Matthijs de Waal, Wiesje M. van der Flier, Jeroen J. M. Hoozemans, Charlotte E. Teunissen

Subjects: Get full text

The membrane-bound aspartyl protease BACE1:Molecular and functional properties in Alzheimer’s disease and beyond by Bastian eDislich, Stefan F Lichtenthaler

Subjects: Get full text

BACE cleavage of APP does not drive the diabetic phenotype of PLB4 mice by Z.J. Franklin, L. Croce, R. Dekeryte, M. Delibegovic, B. Platt

Subjects: Get full text

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease by Miren Ettcheto, Oriol Busquets, Antoni Camins

Subjects: “…Alzheimer’s disease; beta-secretase; neuroinflammation; Tau; amyloid; N-methyl-D-aspartate; glutamate…”
Get full text